Zn-Phenanthroline-Dicarboxylate Complex: A Dual Inhibitor of COX-2 and 5-LOX Enzymes

被引:0
|
作者
Rambabu, Darsi [1 ]
Sharma, Shilpa [2 ]
Mayank [3 ]
Singh, Narinder [2 ]
Shagun [4 ]
Pooja [5 ]
机构
[1] Catholic Univ Louvain, Inst Condensed Matter & Nanosci, B-1348 Louvain La Neuve, Belgium
[2] Indian Inst Technol Ropar, Dept Chem, Rupnagar 140001, India
[3] Univ Coll Pharm, Guru Kashi Univ, Talwandi Sabo 151302, India
[4] Indian Inst Technol Mandi, Sch Chem Sci, Mandi 175001, India
[5] DAV Coll, Post Grad Dept Chem, Jalandhor 144008, Punjab, India
来源
CHEMISTRYSELECT | 2024年 / 9卷 / 23期
关键词
COX-2; 5-LOX; Inhibitors; Metal Complexes; Crystal Structures; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; CYCLOOXYGENASE-2; COX-2; 5-LIPOXYGENASE;
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
A series of new phenanthroline-based metal complexes, coordination polymers are synthesized using 1,10-phenanthroline 2,9-dicarboxylate (PDA) and different metal salts including tin (R-1 to R-3), manganese (R-4), ruthenium (R-5), and zinc (R-6) respectively. The inhibitory activities of synthesized coordination compounds are evaluated towards COX-2 (cyclooxygenase-2) and 5-LOX (5-lipoxygenase) enzymes. Among all the metal-organic coordination complexes, Zn-PDA (R-6) shows most prominent inhibitory activity than other systems with the IC50 value of 0.0524 mu g/mL and 0.834 mu g/mL for both COX-2 and 5-LOX enzymes, respectively. The synthesized systems were also evaluated for their activity against COX-1 and standard COX-2 inhibitors viz. Rofecoxib and Aspirin. The rationale for R-6 being the most potent metal complex for dual COX-2 and 5-LOX inhibition is demonstrated using docking studies. A series of Metal-phenanthroline-carboxylate- coordination compounds (R1 to R6) were designed and synthesized. Among all the metal complexes tested for inhibitory activities for COX-2 and 5-LOX enzymes, the activities of R-1 and R-6 were found to be most potent. image
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Pharmacological evaluation and molecular docking of new di-tert-butylphenol compound, LQFM-091, a new dual 5-LOX/COX inhibitor
    Lino, Roberta Campos
    Bueno da Silva, Daiany Priscila
    Florentino, Iziara Ferreira
    da Silva, Dayane Moreira
    Rodrigues Martins, Jose Luis
    Batista, Daniel da Costa
    de Siqueira Leite, Karla Carneiro
    Villavicencio, Bianca
    Vasconcelos, Gessica A.
    Pereira Silva, Andreia Luiza
    de Avila, Renato Ivan
    Verli, Hugo
    Valadares, Marize Campos
    Gi, Eric de Souza
    Vaz, Boniek G.
    Liao, Luciano M.
    Menegatti, Ricardo
    Costa, Elson Alves
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2017, 106 : 231 - 243
  • [32] Design, synthesis, analgesic, anti-inflammatory activity of novel pyrazolones possessing aminosulfonyl pharmacophore as inhibitors of COX-2/5-LOX enzymes: Histopathological and docking studies
    Abdelgawad, Mohamed A.
    Labib, Madlen B.
    Ali, Waleed A. M.
    Kamel, Gehan
    Azouz, Amany A.
    El-Nahass, EL-Shaymaa
    BIOORGANIC CHEMISTRY, 2018, 78 : 103 - 114
  • [33] The anti-inflammatory pharmacology of Pycnogenol® in humans involves COX-2 and 5-LOX mRNA expression in leukocytes
    Canali, Raffaella
    Comitato, Raffaella
    Schonlau, Frank
    Virgili, Fabio
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2009, 9 (10) : 1145 - 1149
  • [34] Modulation of smoke-induced DNA and microRNA alterations in mouse lung by licofelone, a triple COX- COX-2 and 5-LOX inhibitor
    Izzotti, Alberto
    Balansky, Roumen
    Micale, Rosanna T.
    Pulliero, Alessandra
    La Maestra, Sebastiano
    De Flora, Silvio
    CARCINOGENESIS, 2020, 41 (01) : 91 - 99
  • [35] Discovery of small molecule acting as multitarget inhibitor of colorectal cancer by simultaneous blocking of the key COX-2, 5-LOX and PIM-1 kinase enzymes
    El-Miligy, Mostafa M. M.
    Al-Kubeisi, Ahmed K.
    El-Zemity, Saad R.
    Nassra, Rasha A.
    Abu-Serie, Marwa M.
    Hazzaa, Aly A.
    BIOORGANIC CHEMISTRY, 2021, 115
  • [36] Anti-inflammatory effects and gastrointestinal safety of NNU-hdpa, a novel dual COX/5-LOX inhibitor
    Xu, Guang-Lin
    Liu, Fei
    Ao, Gui-Zhen
    He, Shu-Ying
    Ju, Min
    Zhao, Yue
    Xue, Ting
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2009, 611 (1-3) : 100 - 106
  • [37] VIRTUAL DUAL INHIBITION OF COX-2/5-LOX ENZYMES BASED ON BINDING PROPERTIES OF ALPHA-AMYRINS, THE ANTI-INFLAMMATORY COMPOUND AS A PROMISING ANTI-CANCER DRUG
    Ranjbar, Mohammad Mehdi
    Assadolahi, Vahideh
    Yazdani, Mohsen
    Nikaein, Donya
    Rashidieh, Behnam
    EXCLI JOURNAL, 2016, 15 : 238 - 245
  • [38] Focused library design and synthesis of 2-mercapto benzothiazole linked 1,2,4-oxadiazoles as COX-2/5-LOX inhibitors
    Yatam, Satayanarayana
    Gundla, Rambabu
    Jadav, Surender Singh
    Pedavenkatagari, Narayana Reddy
    Chimakurthy, Jithendra
    Rani, Namratha B.
    Kedam, Thyagaraju
    JOURNAL OF MOLECULAR STRUCTURE, 2018, 1159 : 193 - 204
  • [39] New benzothiophene derivatives as dual COX-1/2 and 5-LOX inhibitors: synthesis, biological evaluation and docking study
    El-Miligy, Mostafa M. M.
    Hazzaa, Aly A.
    El-Messmary, Hanan
    Nassra, Rasha A.
    El-Hawash, Soad A. M.
    FUTURE MEDICINAL CHEMISTRY, 2017, 9 (05) : 443 - 468
  • [40] Evaluation of Cissus quadrangularis extracts as an inhibitor of COX, 5-LOX, and proinflammatory mediators
    Bhujade, Arti M.
    Talmale, Suhas
    Kumar, Naresh
    Gupta, Geetika
    Reddanna, P.
    Das, Samar K.
    Patil, M. B.
    JOURNAL OF ETHNOPHARMACOLOGY, 2012, 141 (03) : 989 - 996